Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns
Go back to Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 214.60 +3.87 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.73 | 52 Week High | $333.65 | |||
| Open | $209.92 | 52 Week Low | $223.02 | |||
| Day High | $216.30 | P/E | 27.48 | |||
| Day Low | $208.93 | EPS | $7.81 | |||
| Volume | 208,501 | |||||
